Andreas has been through the whole life cycle of biotech startups, and is now coming out of the other side. Here’s our conversation on venture, purpose and the industry-academia divide.
It’s been a year since then and now that I finally sit down to write This, the real post mortem, the autopsy for my dead child, there’s finally a small sense of peace.
It’s over, isn’t it?
Who knew a jingle played from a van would be the best way to let people know a GMO mosquito would be released in their area so that they’d go “cool, okay”?
Yes, Oxitec did that.
But how, exactly?
Entrepreneurship feels like standing on a tight rope and being handed a violin, then a flute, then a bass, and suddenly either a balalaika or a chainsaw or both at the same time. And doing as entrepreneurs do: balancing everything and getting on with it.
If you ask any serious investor what’s the most important thing a startup can do they’re likely to mention three things: sell, sell and sell. Us biotech founders though, after receiving the selling mantra, generally get an extra phrase: good luck.
I thought walking the walk was the hardest thing about being an entrepreneur, but not for this. Once everything around you goes down, and after you’ve dropped off the radar to lick your wounds and gather enough strength to come back, it’s time to talk the talk.
Welcome to the talk of shame.
Interested to see how one of the biggest biotech accelerators worldwide is from the inside? Join me in the four-month adventure that is Rebel Bio, SOSV’s global biotech accelerator.